Atsushi Kudo

14PUBLICATIONS
24CO-AUTHORS
Intensive careAquaculture and fisheries stock assessmentRadiation therapyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 06, 2025
Association between incident occurrence and bed configuration: a retrospective observational study in a Japanese academic hospital during the COVID-19 pandemic.

Mutsuko Moriwaki, Mikayo Toba, Chihiro Takahashi

|Feb 15, 2022
Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors.

Hirofumi Watanabe, Fumiyoshi Fujishima, Izumi Komoto

|Dec 15, 2021
Safety and response after peptide receptor radionuclide therapy with 177 Lu-DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trial.

Atsushi Kudo, Ukihide Tateishi, Ryoichi Yoshimura

|Sep 29, 2021
Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasms.

Yoshiki Murase, Atsushi Kudo, Keiichi Akahoshi

|May 13, 2021
A novel classification of portal venous tumor invasion to predict residual tumor status after surgery in patients with pancreatic neuroendocrine neoplasms.

Tomotaka Kato, Atsushi Kudo, Yuko Kinowaki

|Apr 27, 2021
Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy.

Aya Maekawa, Atsushi Kudo, Mitsuhiro Kishino

Pageof 3

Frequent Collaborators

3 joint publications

Minoru Tanabe

2 joint publications

Shinji Tanaka

1 joint publications

Shinji Tanaka

1 joint publications

Yasuhito Iwao